Table 2.
MRD - B-ALL | MRD – T-ALL | ||||||||
---|---|---|---|---|---|---|---|---|---|
<5% | 5–<25% | ≥25% | Total | <5% | 5–<25% | ≥25% | Total | ||
Morphology | M1 | 7 682 (97.8) | 59 (0.8) | 7 (0.1) | 7 748 (98.6) | 1 303 (87.3) | 88 (5.9) | 9 (0.6) | 1 400 (93.8) |
M2 | 28 (0.4) | 29 (0.4) | 11 (0.1) | 68 (0.9) | 10 (0.7) | 25 (1.7) | 15 (1.0) | 50 (3.3) | |
M3 | 2 (0.0) | 5 (0.1) | 34 (0.4) | 41 (0.5) | 0 (0.0) | 5 (0.3) | 38 (2.5) | 43 (2.9) | |
Total | 7 712 (98.2) | 93 (1.2) | 52 (0.7) | 7 857 (100) | 1 313 (87.9) | 118 (7.9) | 62 (4.2) | 1 493 (100) |
ALL – acute lymphoblastic leukemia; MRD – minimal residual disease